| FIRST AUTHOR INDEX |
| Last Name |
First Name |
No. |
Title |
| Nestler |
Eric J. |
SL1
|
New insight into the neurobiology of depression |
| Papakostas |
George I. |
SL3 |
Predictors, moderators, and mediators of treatment outcome in major depressive disorder |
| Barnes |
Thomas R |
CL-1 |
Antipsychotic-induced akathisia and its assessment |
| UCHIDA |
HIROYUKI |
S1-4 |
Tips on how to publish your data in English |
| UCHIDA |
HIROYUKI |
S4-4 |
Individually tailored antipsychotic treatment for schizophrenia: evidence and hypothesis |
| MATSUZAKI |
HIDEO |
S5-1 |
A perspective of biological marker research for autism |
| YAMASUE |
HIDENORI |
S5-4 |
Neural basis of atypical social behavior in people with autism |
| SUZUKI |
KATSUAKI |
S5-5 |
Positron emission tomography imaging studies in autism spectrum disorders |
| Lin |
Ching-Hua |
S8-1 |
Early prediction of psychotropic response |
| Choi |
Sung-Ku |
S8-2 |
Cns drug trials in Asia – Current trend and future |
| Mei |
Si Tian |
S8-3 |
Psychopharmacological clinical trials and researches in China |
| Tateishi |
Tomonori |
S8-4 |
Regulatory perspective on current and future drug developments in psychiatric and neurological diseases in Japan |
| OTSUKI |
KOJI |
S12-1 |
Epigenetic regulation in depression |
| Yamada |
Makiko |
S17-2 |
Neuroimaging of psychiatric symptoms |
| TAKAHASHI |
HIDEHIKO |
S17-3 |
Toward a molecular understanding of altered decision-making in neuropsychiatric disorders |
| HIROI |
NOBORU |
SS-2 |
Genetic mouse model of developmental neuropsychiatric disorders |
| Takeuchi |
Katsuya |
AB |
Overseas Training Report |
| Papakostas |
George I. |
LS2-1 |
Management of Treatment-Resistant Major Depressive Disorder |
| Taylor |
David |
LS2-4 |
Aripiprazole and the maudsley guidelines - a drug for all seasons? |
| Montejo |
Angel L. |
LS3-2 |
Achieving remission preserving quality of life and sexual relationships in depression |
| Barnes |
Thomas R |
ES2-3 |
Improving the quality of prescribing practice in psychiatry: the work of the Prescribing Observatory for Mental Health (POMH-UK) |
| YOSHIDA |
TAKAYUKI |
O2-F2 |
Functional molecular bases of the amygdaloid synaptic transmission involved in extinction of fear memory |
| OHMURA |
YU |
O2-F4 |
Lithium has suppressing effects on impulsive-like action independent of its anorexic effects |
| MIYOSHI |
KO |
O3-G8 |
The neuronal primary cilium, a putative extra-synaptic neurotransmission device, expresses dopamine receptors |
| YOSHIMURA |
REIJI |
O3-I2 |
Aripiprazole altered plasma levels of brain-derived neurotrophic factor, and catecholamine metabolites in fi rst-episode untreated Japanese schizophrenia patients |
| OHNISHI |
YOSHINORI |
P1-C1 |
Differential role of deltaFosB and delta2deltaFosB in response to stress and drugs of abuse |
| OHNISHI |
YOKO |
P1-C2 |
Screening and Identifi cation of protein binding partners of deltaFosB using yeast two hybrid system |
| Goto |
Naoki |
P1-DⅠ5 |
No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage fi rst-episode schizophrenia |
| KOIDE |
TAKAYOSHI |
P1-DⅠ6 |
Evaluation of factors affecting Continuous Performance Test Identical Pairs Version (CPT-IP) score of schizophrenic patients in a Japanese clinical Sample |
| WATANABE |
SHINYA |
P1-DⅡ2 |
Association study of Fat-mass and obesity-associated (FTO) gene and body mass index in a Japanese schizophrenia and healthy Japanese population |
| OHI |
KAZUTAKA |
P1-DⅡ6 |
The KCNH2 gene is associated with neurocognition and the risk of Schizophrenia |
| Hashimoto |
Ryota |
P1-DⅢ1 |
RELA Gene is associated with risk for schizophrenia and defi cits in prepulse Inhibition |
| NAKATAKI |
MASAHITO |
P1-DⅢ5 |
Amino acid neurotransmission in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study |
| ISHITOBI |
MAKOTO |
P1-DⅥ2 |
Adjunctive treatment with low-dosage pramipexole for risperidoneinduced hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia |
| UTSUNOMIYA |
KENSUKE |
P1-KⅠ1 |
Association analysis between the 1,alpha-Hydroxylase (CYP27B1) gene polymorphisms and late-onset Alzheimer's disease |
| NAKATANI |
YOSHIHIKO |
P2-AⅡ1 |
The effect of corticosterone to immunoreactive cell lines |
| Yun |
Jaesuk |
P2-AⅡ4 |
Npas4 regulates neurite outgrowth and phosphoryation of synapsin I |
| MORIGUCHI |
SHIGEKI |
P2-BⅡ1 |
Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in 1-metyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice |
| EZUMI |
SATORU |
P2-BⅡ2 |
Difference in the effect of Imipramine and GBR12909 on the Runway method using priming stimulation effect (PSE) of the intracranial selfstimulation (ICSS) behavior |
| UCHIDA |
HIROYUKI |
P2-GⅥ1 |
Predicting antipsychotic plasma concentrations before titrating the dose: a population pharmacokinetic study |
| TSUTSUMI |
CHISA |
P2-GⅥ4 |
The evolution of antipsychotic switch and polypharmacy in natural practice - a longitudinal perspective |
| KUROIWA |
MAHOMI |
P2-HⅢ3 |
Effect of chronic fl uoxetine treatment on dopamine D1 receptor signaling in the hippocampal dentate gyrus |
| IGA |
JUNICHI |
P2-IⅢ3 |
SOCS3, a candidate gene for the molecular effects of lithium and pathophysiology of MDD |
